Lv11
40 积分 2025-10-26 加入
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
4小时前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
4小时前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
4小时前
已完结
Coptidis Rhizoma and Berberine as Anti-cancer Drugs: a 10-year updates and future perspectives
2个月前
已完结
Berberine protects against hypoxia-induced intestinal injury through modulation of gut microbiota and bile acid metabolism
2个月前
已完结
Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action
2个月前
已完结
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
7个月前
已完结
皖公网安备34019202002308
